Literature DB >> 27448299

Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation.

Donghao Shang1, Tie Zheng2,3, Jian Zhang1, Ye Tian1, Yuting Liu4.   

Abstract

The molecular mechanism and signal transduction pathways involved in urothelial cancer (UC) after renal transplantation (RTx) remain unknown. In this study, we investigated the profiling of messenger RNA (mRNA) and long non-coding RNA (lncRNA) in RTx recipients with UC. The mRNA and lncRNA of six pairs of UC and corresponding normal urothelial tissues in RTx recipients were profiled using Arraystar Human lncRNA Microarray V3.0, which is designed for the global profiling of 26,109 coding transcripts and 30,586 lncRNAs. Quantitative real-time PCR (qRT-PCR) was used to validate the differentially expressed mRNAs and lncRNAs. Molecular function classification and biological process classification for the differentially expressed mRNAs were analyzed with Gene Ontology. The key pathways that were associated with UC after RTx were analyzed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Compared to normal urothelial tissues, 1597 mRNAs were upregulated and 1032 mRNAs were downregulated in UC; 2107 lncRNAs were upregulated and 1794 lncRNAs were downregulated (greater than twofold). Further qRT-PCR analysis of mRNA and lncRNA expression showed well consistency with the data of microarray analysis. The expression of matrix metalloprotease (MMP)-3, MMP-10, MMP-12, and MMP-13 was significantly increased, while the expression of CD36 was decreased in UC after RTx. Co-expression analysis of lncRNAs and their nearby coding genes showed that lncRNAs may play critical roles in regulating nearby genes in the carcinogenesis of UC. Our results also suggest that peroxisome proliferator-activated receptor (PPAR) signaling may be involved in UC after RTx. Moreover, several cytokines and their receptors were also significantly upregulated in UC after RTx, suggesting that cytokines might be modulated and participated in the carcinogenesis of UC after RTx. We analyzed the potential molecular mechanism and pathways involved in the UC of RTx recipients. Our results revealed that several key regulatory pathways and lncRNAs play critical roles in the carcinogenesis of UC, and suggest that UC in RTx recipients may be more likely to invade and metastasis. However, the detailed functional analysis of these mechanisms should be further performed in the future.

Entities:  

Keywords:  Gene expression; Renal transplantation; Urothelial cancer; lncRNA

Mesh:

Substances:

Year:  2016        PMID: 27448299     DOI: 10.1007/s13277-016-5148-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  58 in total

1.  Human papillomavirus-related bladder cancer following renal transplantation.

Authors:  P D McInerney; C G Koffman; A R Mundy
Journal:  Br J Urol       Date:  1993-11

2.  The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.

Authors:  Alistair Rogers; Jenny Koo Ng; James Glendinning; David Rix
Journal:  BJU Int       Date:  2012-01-13       Impact factor: 5.588

3.  Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics.

Authors:  P Swindle; M Falk; R Rigby; J Petrie; C Hawley; D Nicol
Journal:  Br J Urol       Date:  1998-02

4.  Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations.

Authors:  P Vogt; U Frei; H Repp; H Bunzendahl; K Oldhafer; R Pichlmayr
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

5.  Urothelial malignancy in nephropathy due to Chinese herbs.

Authors:  J P Cosyns; M Jadoul; J P Squifflet; P J Van Cangh; C van Ypersele de Strihou
Journal:  Lancet       Date:  1994-07-16       Impact factor: 79.321

6.  Cancer incidence among Canadian kidney transplant recipients.

Authors:  P J Villeneuve; D E Schaubel; S S Fenton; F A Shepherd; Y Jiang; Y Mao
Journal:  Am J Transplant       Date:  2007-02-28       Impact factor: 8.086

7.  CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.

Authors:  Fanbin Meng; Wan Li; Changling Li; Zhigang Gao; Kejian Guo; Shaowei Song
Journal:  Int J Oncol       Date:  2014-12-10       Impact factor: 5.650

8.  MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.

Authors:  Ferenc Sipos; Tiana M Germann; Barnabás Wichmann; Orsolya Galamb; Sándor Spisák; Tibor Krenács; Zsolt Tulassay; Béla Molnár; Györgyi Műzes
Journal:  Eur J Cancer Prev       Date:  2014-09       Impact factor: 2.497

9.  Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance.

Authors:  Nathalie Vigneron; Nicolas van Baren; Benoît J Van den Eynde
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 10.  Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.

Authors:  Michael Platten; Nikolaus von Knebel Doeberitz; Iris Oezen; Wolfgang Wick; Katharina Ochs
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

View more
  5 in total

1.  Peroxisome proliferator-activated receptor γ (PPARγ) suppresses the proliferation and metastasis of patients with urothelial carcinoma after renal transplantation by inhibiting LEF1/β-catenin signaling.

Authors:  Donghao Shang; Yuting Liu; Jian Zhang; Xinyi Hu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

2.  Recounting the FANTOM CAGE-Associated Transcriptome.

Authors:  Eddie Luidy Imada; Diego Fernando Sanchez; Ben Langmead; Luigi Marchionni; Leonardo Collado-Torres; Christopher Wilks; Tejasvi Matam; Wikum Dinalankara; Aleksey Stupnikov; Francisco Lobo-Pereira; Chi-Wai Yip; Kayoko Yasuzawa; Naoto Kondo; Masayoshi Itoh; Harukazu Suzuki; Takeya Kasukawa; Chung-Chau Hon; Michiel J L de Hoon; Jay W Shin; Piero Carninci; Andrew E Jaffe; Jeffrey T Leek; Alexander Favorov; Gloria R Franco
Journal:  Genome Res       Date:  2020-02-20       Impact factor: 9.043

3.  Aberrant expression of long non-coding RNAs (lncRNAs) is involved in brain glioma development.

Authors:  Yi Ding; Xinfa Wang; Junchen Pan; Minjun Ji; Zhengxiang Luo; Penglai Zhao; Yansong Zhang; Gang Wang
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

4.  Long non-coding RNA ERICH3-AS1 is an unfavorable prognostic factor for gastric cancer.

Authors:  Qiongyun Chen; Xiaoqing Huang; Xuan Dong; Jingtong Wu; Fei Teng; Hongzhi Xu
Journal:  PeerJ       Date:  2020-01-28       Impact factor: 2.984

5.  A porcine model to study the effect of brain death on kidney genomic responses.

Authors:  Mitchell B Sally; Darren J Malinoski; Frank P Zaldivar; Tony Le; Matin Khoshnevis; William A Pinette; Michael Hutchens; Shlomit Radom-Aizik
Journal:  J Clin Transl Sci       Date:  2018-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.